AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2018
Sep 4, 2018
34983_dirs_2018-09-04_efd52ad0-9996-4379-b4cc-72b680dccb65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20
Reporting Person: DOCHERTY JOHN MARTIN (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-31 | Common Shares | A | 36500 | $2.07 | Acquired | 1622250 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 1585750 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $0.09 | 2020-03-26 | Common Shares (550000) | 550000 | Direct |
| Stock Options | $0.11 | 2021-04-15 | Common Shares (300000) | 850000 | Direct |
| Stock Options | $1.53 | 2023-05-31 | Common Shares (400000) | 1250000 | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19